CI
AZN icon

Corient IA’s AstraZeneca AZN Stock Holding History

Corient IA’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$448K Hold
2,315
– – 0.42% 75
2025
Q4 		$426K Sell
2,315
-1,185
-34% -$208K 0.4% 95
2025
Q3 		$537K Hold
3,500
– – 0.4% 82
2025
Q2 		$489K Hold
3,500
– – 0.29% 124
2025
Q1 		$515K Buy
+3,500
New +$506K 0.37% 98

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

Corient IA's AZN Position: Q1 2026 in Review

Corient IA held its AstraZeneca (AZN) position steady in Q1 2026 at 2,315 shares worth $448K. The position accounts for 0.42% of the portfolio, ranked #75.

Corient IA first reported a position in AZN in Q1 2025 and has held it in 5 quarters since. The position peaked at $537K in Q3 2025. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Corient IA held 2,315 shares of AstraZeneca worth $448K as of Q1 2026.
  • Corient IA left its AstraZeneca share count unchanged in Q1 2026.
  • AstraZeneca made up 0.42% of Corient IA's portfolio in Q1 2026, its #75 holding.
  • Corient IA first reported a position in AstraZeneca in Q1 2025 and has held it in 5 quarters since.
  • Corient IA's AstraZeneca position peaked at $537K in Q3 2025.
  • 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Corient IA's 13F filing for Q1 2026, filed 14 May 2026.